Mechanistically, TRIM26 ubiquitinates and targets ZEB1 for degradation, while USP39 deubiquitinates and stabilizes ZEB1 to promote hepatocellular carcinoma (HCC) [86]. Here, ZEB1 is linked to hepatocellular carcinoma.